Role and natural host targets of Shigella IpaH during infection
Numerous pathogens grow inside host cells. During the intracellular stage of infection, pathogen proteins establish intricate interactions with host proteins to hijack their cellular machinery. The bacterium Shigella flexneri thri...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CAGECONTROL
Identification and manipulation of factors that control Shig...
225K€
Cerrado
SHIGELLA INDUCED EMT
Diversion of adherens junctions by bacterial type III effect...
100K€
Cerrado
ENTRAPMENT
Septins from bacterial entrapment to cellular immunity
3M€
Cerrado
BIO2010-18885
BIOLOGIA DEL PEPTIDOGLICANO DE SALMONELLA EN EL INTERIOR DE...
327K€
Cerrado
EndoSubvert
Common mechanisms of host membrane trafficking subversion by...
2M€
Cerrado
SAF2010-15015
ESTUDIO FUNCIONAL Y ESTRUCTURAL DE EFECTORES DE LOS SISTEMAS...
145K€
Cerrado
Información proyecto IpaH functions
Líder del proyecto
INSTITUT PASTEUR
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
63K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Numerous pathogens grow inside host cells. During the intracellular stage of infection, pathogen proteins establish intricate interactions with host proteins to hijack their cellular machinery. The bacterium Shigella flexneri thrives in the cytoplasm of human intestinal epithelial cells. To do so this bacterium must inject proteins that are dubbed effectors before and after cell invasion. IpaH are an uncommonly large family of effectors, comprising 9 members, for example, in S. flexneri 5. These proteins are hypothesized to interfere with normal cellular function by deregulating their degradation by the ubiquitin-proteasome system. Although IpaH9.8 has been implicated in dampening the innate immune response, diversity in the putative substrate binding domain across the IpaH family indicates that there might be other targets. Thus, the primary objectives of this project are: 1) perform a spatio-temporal study of the transcription, injection and sub cellular localization of IpaH effectors inside infected cell; 2) track the host cell protein targeted to the proteasome by the IpaH. In the frame of this project, I will develop a multidisciplinary strategy to study host-pathogen interactions by combining proteomics and cell biology approaches, pathophysiologic models of Shigellosis and computer simulations.